ArticleInternational journal of cancer2019

Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models.

Tatsuo Sugawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.